RhoA/Rho-kinase and vascular diseases: What is the link?

Cellular and Molecular Life Sciences

Volumn 67, Issue 22, 2010, Pages 3823-3836

  Nunes, Kenia Pedrosa ^a   Rigsby, Christine S ^a   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cancer; Cardiovascular diseases; Diabetes; Erectile dysfunction; Pulmonary hypertension; Rho kinase; RhoA

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALCIUM; CCG 1423; FASUDIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOENZYME; MYOSIN LIGHT CHAIN KINASE; PITAVASTATIN; PROTEIN SERINE THREONINE KINASE; RHO KINASE; RHO KINASE INHIBITOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SAR 407899; SILDENAFIL; SIMVASTATIN; UNCLASSIFIED DRUG;

ACTIN MYOSIN INTERACTION; AIRWAY RESISTANCE; ARTERIAL PRESSURE; ATHEROSCLEROSIS; BLOOD FLOW; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ERECTILE DYSFUNCTION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; INTESTINE MOTILITY; LUNG ARTERY PRESSURE; MALIGNANT NEOPLASTIC DISEASE; MUSCLE FIBER CONTRACTION; MYOFILAMENT; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVIEW; SMOOTH MUSCLE TONE; VASCULAR DISEASE;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; ERECTILE DYSFUNCTION; HUMANS; HYPERTENSION, PULMONARY; MALE; NEOPLASMS; RHO-ASSOCIATED KINASES;

EID: 78149469722     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0460-1     Document Type: Review

References (168)

1. M Amano Y Fukata K Kaibuchi 2000 Regulation and functions of Rho-associated kinase Exp Cell Res 261 44 51 11082274 1:CAS:528: DC%2BD3cXotVyntL8%3D
2. AJ Ridley 2001 Rho family proteins: coordinating cell responses Trends Cell Biol 11 471 477 11719051 1:CAS:528:DC%2BD3MXosFKls78%3D
3. O Nakagawa K Fujisawa T Ishizaki Y Saito K Nakao S Narumiya 1996 ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice FEBS Lett 392 189 193 8772201 1:CAS:528:DyaK28Xlt1Kitrk%3D
4. N Wettschureck S Offermanns 2002 Rho/Rho-kinase mediated signaling in physiology and pathophysiology J Mol Med 80 629 638 12395147 1:CAS:528:DC%2BD38XotVClt7s%3D
5. H Shimokawa 2002 Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases J Cardiovasc Pharmacol 39 319 327 11862109 1:CAS:528:DC%2BD38XitVGmtLc%3D
6. AP Somlyo AV Somlyo 2004 Signal transduction through the RhoA/Rho-kinase pathway in smooth muscle J Muscle Res Cell Motil 25 613 615 15750846
7. Y Kureishi S Kobayashi M Amano K Kimura H Kanaide T Nakano K Kaibuchi M Ito 1997 Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation J Biol Chem 272 12257 12260 9139666 1:CAS:528:DyaK2sXjtFyns7k%3D
8. MJ Berridge 2008 Smooth muscle cell calcium activation mechanisms J Physiol 586 5047 5061 18787034 1:CAS:528:DC%2BD1cXhsVClsLjE
9. J Hiroki H Shimokawa M Higashi K Morikawa T Kandabashi N Kawamura T Kubota T Ichiki M Amano K Kaibuchi A Takeshita 2004 Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells J Mol Cell Cardiol 37 537 546 15276023 1:CAS:528:DC%2BD2cXmtVais7o%3D
10. SA Barman S Zhu RE White 2009 RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension Vasc Health Risk Manag 5 663 671 19707285 1:CAS:528:DC%2BD1MXhtVyltrfL
11. BH Gao ST Zhao FW Meng BK Shi YQ Liu ZS Xu 2007 Y-27632 improves the erectile dysfunction with ageing in SD rats through adjusting the imbalance between nNo and the Rho-kinase pathways Andrologia 39 146 150 17683464 1:CAS:528:DC%2BD2sXps1Siu7o%3D
12. Y Nakamura H Kaneto T Miyatsuka TA Matsuoka M Matsuhisa K Node M Hori Y Yamasaki 2006 Marked increase of insulin gene transcription by suppression of the Rho/Rho-kinase pathway Biochem Biophys Res Commun 350 68 73 16996478 1:CAS:528:DC%2BD28XhtVagtr7I
13. YW Chang RR Bean R Jakobi 2009 Targeting RhoA/Rho kinase and p21-activated kinase signaling to prevent cancer development and progression Recent Pat Anticancer Drug Discov 4 110 124 19519534 1:CAS:528: DC%2BD1MXmsFWgs7g%3D
14. PV LoGrasso Y Feng 2009 Rho kinase (ROCK) inhibitors and their application to inflammatory disorders Curr Top Med Chem 9 704 723 19689376 1:CAS:528:DC%2BD1MXhtFehsLnN
15. JK Liao M Seto K Noma 2007 Rho kinase (ROCK) inhibitors J Cardiovasc Pharmacol 50 17 24 17666911 1:CAS:528:DC%2BD2sXosFGju7o%3D
16. EM Sorokina J Chernoff 2005 Rho-GTPases: new members, new pathways J Cell Biochem 94 225 231 15543593 1:CAS:528:DC%2BD2MXpsFehtQ%3D%3D
17. Y Fukata M Amano K Kaibuchi 2001 Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells Trends Pharmacol Sci 22 32 39 11165670 1:CAS:528:DC%2BD3MXpslynug%3D%3D
18. AB Jaffe A Hall 2005 Rho GTPases: biochemistry and biology Annu Rev Cell Dev Biol 21 247 269 16212495 1:CAS:528:DC%2BD2MXhtlektbrI
19. K Riento AJ Ridley 2003 Rocks: multifunctional kinases in cell behaviour Nat Rev Mol Cell Biol 4 446 456 12778124 1:CAS:528:DC%2BD3sXktFOnsrc%3D
20. D Komander R Garg PT Wan AJ Ridley D Barford 2008 Mechanism of multi-site phosphorylation from a ROCK-I: RhoE complex structure EMBO J 27 3175 3185 18946488 1:CAS:528:DC%2BD1cXhtl2gsLnJ
21. K Riento N Totty P Villalonga R Garg R Guasch AJ Ridley 2005 RhoE function is regulated by ROCK I-mediated phosphorylation EMBO J 24 1170 1180 15775972 1:CAS:528:DC%2BD2MXjsVejs7k%3D
22. T Kurokawa Y Yumiya H Fujisawa S Shirao S Kashiwagi M Sato H Kishi S Miwa K Mogami S Kato T Akimura M Soma K Ogasawara A Ogawa S Kobayashi M Suzuki 2009 Elevated concentrations of sphingosylphosphorylcholine in cerebrospinal fluid after subarachnoid hemorrhage: a possible role as a spasmogen J Clin Neurosci 16 1064 1068 19596114 1:CAS:528:DC%2BD1MXosVGhsLk%3D
23. T Matsui M Amano T Yamamoto K Chihara M Nakafuku M Ito T Nakano K Okawa A Iwamatsu K Kaibuchi 1996 Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho EMBO J 15 2208 2216 8641286 1:CAS:528:DyaK28XjtFyjtrY%3D
24. A Yoneda HA Multhaupt JR Couchman 2005 The Rho kinases I and II regulate different aspects of myosin II activity J Cell Biol 170 443 453 16043513 1:CAS:528:DC%2BD2MXntVaku7c%3D
25. M Sebbagh C Renvoize J Hamelin N Riche J Bertoglio J Breard 2001 Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing Nat Cell Biol 3 346 352 11283607 1:CAS:528: DC%2BD3MXivVygsbg%3D
26. Y Wang XR Zheng N Riddick M Bryden W Baur X Zhang HK Surks 2009 ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells Circ Res 104 531 540 19131646 1:CAS:528:DC%2BD1MXhvFejtLs%3D
27. D Thumkeo J Keel T Ishizaki M Hirose K Nonomura H Oshima M Oshima MM Taketo S Narumiya 2003 Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death Mol Cell Biol 23 5043 5055 12832488 1:CAS:528:DC%2BD3sXltleksrw%3D
28. G Loirand P Guerin P Pacaud 2006 Rho kinases in cardiovascular physiology and pathophysiology Circ Res 98 322 334 16484628 1:CAS:528:DC%2BD28Xht1Cmtbg%3D
29. L Wei W Roberts L Wang M Yamada S Zhang Z Zhao SA Rivkees RJ Schwartz K Imanaka-Yoshida 2001 Rho kinases play an obligatory role in vertebrate embryonic organogenesis Development 128 2953 2962 11532918 1:CAS:528:DC%2BD3MXmtlCrtLo%3D
30. F Di Cunto S Imarisio E Hirsch V Broccoli A Bulfone A Migheli C Atzori E Turco R Triolo GP Dotto L Silengo F Altruda 2000 Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis Neuron 28 115 127 11086988 1:CAS:528:DC%2BD3cXnvVGlt7Y%3D
31. K Yamashita Y Kotani Y Nakajima M Shimazawa S Yoshimura S Nakashima T Iwama H Hara 2007 Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons Brain Res 1154 215 224 17482584 1:CAS:528:DC%2BD2sXmt1ynsb0%3D
32. T Leung E Manser L Tan L Lim 1995 A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes J Biol Chem 270 29051 29054 7493923 1:CAS:528:DyaK2MXpvVOhtLc%3D
33. V Chevrier M Piel N Collomb Y Saoudi R Frank M Paintrand S Narumiya M Bornens D Job 2002 The Rho-associated protein kinase p160ROCK is required for centrosome positioning J Cell Biol 157 807 817 12034773 1:CAS:528: DC%2BD38XktFCktLk%3D
34. VP Sah TM Seasholtz SA Sagi JH Brown 2000 The role of Rho in G protein-coupled receptor signal transduction Annu Rev Pharmacol Toxicol 40 459 489 10836144 1:CAS:528:DC%2BD3cXjs1yhtrY%3D
35. Y Mizuno E Isotani J Huang H Ding JT Stull KE Kamm 2008 Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo Am J Physiol Cell Physiol 295 C358 C364 18524939 1:CAS:528:DC%2BD1cXhtVaktr7L
36. AC Newton 1995 Protein kinase C: structure, function, and regulation J Biol Chem 270 28495 28498 7499357 1:CAS:528:DyaK2MXpslOjs7w%3D
37. RH Hilgers RC Webb 2005 Molecular aspects of arterial smooth muscle contraction: focus on Rho Exp Biol Med (Maywood) 230 829 835 1:CAS:528:DC%2BD2MXhtlals7nE
38. A Muranyi D Derkach F Erdodi A Kiss M Ito DJ Hartshorne 2005 Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells FEBS Lett 579 6611 6615 16297917 1:CAS:528:DC%2BD2MXht1OlurnK
39. M Eto T Ohmori M Suzuki K Furuya F Morita 1995 A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization J Biochem 118 1104 1107 8720121 1:CAS:528:DyaK28Xhtleks7k%3D
40. M Koyama M Ito J Feng T Seko K Shiraki K Takase DJ Hartshorne T Nakano 2000 Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase FEBS Lett 475 197 200 10869555 1:CAS:528:DC%2BD3cXktlKqsro%3D
41. HK Surks N Riddick K Ohtani 2005 M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells J Biol Chem 280 42543 42551 16257966 1:CAS:528:DC%2BD2MXhtlCmsLvL
42. Y Koga M Ikebe 2005 p116Rip decreases myosin II phosphorylation by activating myosin light chain phosphatase and by inactivating RhoA J Biol Chem 280 4983 4991 15545284 1:CAS:528:DC%2BD2MXhtVymtbk%3D
43. L Jin Z Ying RH Hilgers J Yin X Zhao JD Imig RC Webb 2006 Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats J Pharmacol Exp Ther 318 288 295 16569756 1:CAS:528:DC%2BD28XmsFymt7o%3D
44. Q Zhou JK Liao 2009 Rho kinase: an important mediator of atherosclerosis and vascular disease Curr Pharm Des 15 3108 3115 19754385 1:CAS:528: DC%2BD1MXhtVaht7jK
45. SA Hamid HS Bower GF Baxter 2007 Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium Am J Physiol Heart Circ Physiol 292 H2598 H2606 17220176 1:CAS:528:DC%2BD2sXmvF2ltb4%3D
46. Y Rikitake HH Kim Z Huang M Seto K Yano T Asano MA Moskowitz JK Liao 2005 Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection Stroke 36 2251 2257 16141422 1:CAS:528:DC%2BD2MXhtVeisbnP
47. M Sato E Tani H Fujikawa K Kaibuchi 2000 Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm Circ Res 87 195 200 10926869 1:CAS:528:DC%2BD3cXlsFygsrc%3D
48. M Higashi H Shimokawa T Hattori J Hiroki Y Mukai K Morikawa T Ichiki S Takahashi A Takeshita 2003 Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system Circ Res 93 767 775 14500337 1:CAS:528:DC%2BD3sXnvFags7c%3D
49. W Bao E Hu L Tao R Boyce R Mirabile DT Thudium XL Ma RN Willette TL Yue 2004 Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury Cardiovasc Res 61 548 558 14962485 1:CAS:528:DC%2BD2cXhtFWmsb4%3D
50. K Miyata H Shimokawa T Kandabashi T Higo K Morishige Y Eto K Egashira K Kaibuchi A Takeshita 2000 Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo Arterioscler Thromb Vasc Biol 20 2351 2358 11073837 1:CAS:528:DC%2BD3cXptVSis7g%3D
51. XF Ming H Viswambharan C Barandier J Ruffieux K Kaibuchi S Rusconi Z Yang 2002 Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells Mol Cell Biol 22 8467 8477 12446767 1:CAS:528: DC%2BD38XptlGrsLw%3D
52. S Wolfrum A Dendorfer Y Rikitake TJ Stalker Y Gong R Scalia P Dominiak JK Liao 2004 Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection Arterioscler Thromb Vasc Biol 24 1842 1847 15319269 1:CAS:528: DC%2BD2cXotVOntrg%3D
53. S Dimmeler I Fleming B Fisslthaler C Hermann R Busse AM Zeiher 1999 Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 601 605 10376603 1:CAS:528:DyaK1MXjvFegu7s%3D
54. ZP Chen KI Mitchelhill BJ Michell D Stapleton I Rodriguez-Crespo LA Witters DA Power PR Ortiz de Montellano BE Kemp 1999 AMP-activated protein kinase phosphorylation of endothelial NO synthase FEBS Lett 443 285 289 10025949 1:CAS:528:DyaK1MXht1Sgt7c%3D (Pubitemid 29080812)
55. T Kishi Y Hirooka A Masumoto K Ito Y Kimura K Inokuchi T Tagawa H Shimokawa A Takeshita K Sunagawa 2005 Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure Circulation 111 2741 2747 15927989 1:CAS:528:DC%2BD2MXksVait7w%3D
56. H Shimokawa K Hiramori H Iinuma S Hosoda H Kishida H Osada T Katagiri K Yamauchi Y Yui T Minamino M Nakashima K Kato 2002 Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study J Cardiovasc Pharmacol 40 751 761 12409984 1:CAS:528:DC%2BD38Xot12mtb0%3D
57. L Miao JW Calvert J Tang AD Parent JH Zhang 2001 Age-related RhoA expression in blood vessels of rats Mech Ageing Dev 122 1757 1770 11557278 1:CAS:528:DC%2BD3MXms12lsbs%3D
58. H Kai H Kudo N Takayama S Yasuoka H Kajimoto T Imaizumi 2009 Large blood pressure variability and hypertensive cardiac remodeling-role of cardiac inflammation Circ J 73 2198 2203 19875896
59. Cousin M, Custaud MA, Baron-Menguy C, Toutain B, Dumont O, Guihot AL, Vessieres E, Subra JF, Henrion D, Loufrani L (2010) Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries. Hypertension 55:109-115
60. JP Wesselman JG De Mey 2002 Angiotensin and cytoskeletal proteins: role in vascular remodeling Curr Hypertens Rep 4 63 70 11790294
61. Wynne BM, Chiao C-W, Webb RC (2009) Vascular smooth muscle cell signaling mechanism for construction to angiotensin II and endothelin-1. J Am Soc Hypertension 3:84-95
62. Zhong Y, Hennig B, Toborek M (2010) Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cells. J Cereb Blood Flow Metab 30:522-533
63. H Xiao C Neuveut HL Tiffany M Benkirane EA Rich PM Murphy KT Jeang 2000 Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1 Proc Natl Acad Sci USA 97 11466 11471 11027346 1:CAS:528:DC%2BD3cXnsF2qs78%3D
64. Y Fukumoto S Tawara H Shimokawa 2007 Recent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitors Tohoku J Exp Med 211 309 320 17409670 1:CAS:528:DC%2BD2sXltFKktL0%3D
65. S Wakino T Kanda K Hayashi 2005 Rho/Rho kinase as a potential target for the treatment of renal disease Drug News Perspect 18 639 643 16491166 1:CAS:528:DC%2BD28Xkt1Krt7w%3D
66. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr DW Jones BJ Materson S Oparil JT Wright Jr EJ Roccella 2003 The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 2560 2572 12748199 1:CAS:528:DC%2BD3sXjvFCqtrk%3D (Pubitemid 37430158)
67. Y Kokubo K Kamide 2009 High-normal blood pressure and the risk of cardiovascular disease Circ J 73 1381 1385 19602774
68. A Masumoto Y Hirooka H Shimokawa K Hironaga S Setoguchi A Takeshita 2001 Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans Hypertension 38 1307 1310 11751708 1:CAS:528:DC%2BD38Xitl2rsA%3D%3D
69. M Uehata T Ishizaki H Satoh T Ono T Kawahara T Morishita H Tamakawa K Yamagami J Inui M Maekawa S Narumiya 1997 Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension Nature 389 990 994 9353125 1:CAS:528:DyaK2sXntVarsbY%3D
70. K Ito Y Hirooka K Sakai T Kishi K Kaibuchi H Shimokawa A Takeshita 2003 Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension Circ Res 92 1337 1343 12791705 1:CAS:528:DC%2BD3sXks1Kms7Y%3D
71. K Ito Y Hirooka T Kishi Y Kimura K Kaibuchi H Shimokawa A Takeshita 2004 Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition Hypertension 43 156 162 14732730 1:CAS:528:DC%2BD2cXlvFeitg%3D%3D
72. M Takemoto J Sun J Hiroki H Shimokawa JK Liao 2002 Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase Circulation 106 57 62 12093770 1:CAS:528:DC%2BD38XlvVWitr8%3D
73. HK Shin S Salomone EM Potts SW Lee E Millican K Noma PL Huang DA Boas JK Liao MA Moskowitz C Ayata 2007 Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms J Cereb Blood Flow Metab 27 998 1009 17033691 1:CAS:528:DC%2BD2sXlvVSkt7w%3D
74. Y Mukai H Shimokawa T Matoba T Kandabashi S Satoh J Hiroki K Kaibuchi A Takeshita 2001 Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension FASEB J 15 1062 1064 11292668 1:CAS:528:DC%2BD3MXivFOrtb0%3D
75. N Moriki M Ito T Seko Y Kureishi R Okamoto T Nakakuki M Kongo N Isaka K Kaibuchi T Nakano 2004 RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats Hypertens Res 27 263 270 15127884 1:CAS:528:DC%2BD2cXlsVCqtL4%3D
76. Hahmann C, Schroeter T (2010) Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity. Cell Mol Life Sci 67:171-177
77. M Lohn O Plettenburg Y Ivashchenko A Kannt A Hofmeister D Kadereit M Schaefer W Linz M Kohlmann JM Herbert P Janiak SE O'Connor H Ruetten 2009 Pharmacological characterization of SAR407899, a novel rho-kinase inhibitor Hypertension 54 676 683 19597037
78. Z Mallat A Gojova V Sauzeau V Brun JS Silvestre B Esposito R Merval H Groux G Loirand A Tedgui 2003 Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice Circ Res 93 884 888 14525807 1:CAS:528:DC%2BD3sXotlejsrc%3D
79. HW Wang PY Liu N Oyama Y Rikitake S Kitamoto J Gitlin JK Liao WA Boisvert 2008 Deficiency of ROCK1 in bone marrow-derived cells protects against atherosclerosis in LDLR-/- mice FASEB J 22 3561 3570 18556458 1:CAS:528:DC%2BD1cXht1SqsrbI
80. CP Cannon E Braunwald CH McCabe DJ Rader JL Rouleau R Belder SV Joyal KA Hill MA Pfeffer AM Skene 2004 Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 1495 1504 15007110 1:CAS:528:DC%2BD2cXjtVeqtr8%3D
81. T Ito U Ikeda M Shimpo R Ohki M Takahashi K Yamamoto K Shimada 2002 HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells Cardiovasc Drugs Ther 16 121 126 12090904 1:CAS:528:DC%2BD38XkvVWqt70%3D (Pubitemid 34787793)
82. Y Rikitake JK Liao 2005 Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells Circulation 111 3261 3268 15956119 1:CAS:528:DC%2BD2MXltVKmtr0%3D
83. U Laufs M Endres N Stagliano S Amin-Hanjani DS Chui SX Yang T Simoncini M Yamada E Rabkin PG Allen PL Huang M Bohm FJ Schoen MA Moskowitz JK Liao 2000 Neuroprotection mediated by changes in the endothelial actin cytoskeleton J Clin Invest 106 15 24 10880044 1:CAS:528:DC%2BD3cXks1yrsrc%3D
84. A Nohria A Prsic PY Liu R Okamoto MA Creager A Selwyn JK Liao P Ganz 2009 Statins inhibit Rho kinase activity in patients with atherosclerosis Atherosclerosis 205 517 521 19167712 1:CAS:528:DC%2BD1MXptVelsLg%3D
85. M Rekhter K Chandrasekhar D Gifford-Moore XD Huang P Rutherford J Hanson R Kauffman 2007 Immunohistochemical analysis of target proteins of Rho-kinase in a mouse model of accelerated atherosclerosis Exp Clin Cardiol 12 169 174 18651000 1:CAS:528:DC%2BD1cXhtFGrurs%3D
86. BK Mueller H Mack N Teusch 2005 Rho kinase, a promising drug target for neurological disorders Nat Rev Drug Discov 4 387 398 15864268 1:CAS:528:DC%2BD2MXjs1OktLw%3D
87. JF Borisoff CC Chan GW Hiebert L Oschipok GS Robertson R Zamboni JD Steeves W Tetzlaff 2003 Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates Mol Cell Neurosci 22 405 416 12691741 1:CAS:528:DC%2BD3sXis1yqtLw%3D
88. A Masumoto M Mohri H Shimokawa L Urakami M Usui A Takeshita 2002 Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina Circulation 105 1545 1547 11927519 1:CAS:528:DC%2BD38XjtlCmtLk%3D
89. JC Mills NL Stone RN Pittman 1999 Extranuclear apoptosis. The role of the cytoplasm in the execution phase J Cell Biol 146 703 708 10459006 1:CAS:528:DyaK1MXls1Srtrc%3D
90. S Satoh Y Toshima A Hitomi I Ikegaki M Seto T Asano 2008 Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model Brain Res 1193 102 108 18187127 1:CAS:528: DC%2BD1cXitVWns7s%3D
91. A Hitomi S Satoh I Ikegaki Y Suzuki M Shibuya T Asano 2000 Hemorheological abnormalities in experimental cerebral ischemia and effects of protein kinase inhibitor on blood fluidity Life Sci 67 1929 1939 11072869 1:CAS:528:DC%2BD3cXms1Cgs7s%3D
92. S Satoh T Kobayashi A Hitomi I Ikegaki Y Suzuki M Shibuya J Yoshida T Asano 1999 Inhibition of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction Jpn J Pharmacol 80 41 48 10446755 1:CAS:528:DyaK1MXjtlGis74%3D
93. Ding J, Li QY, Yu JZ, Wang X, Sun CH, Lu CZ, Xiao BG (2010) Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice. Mol Cell Neurosci 43:201-208
94. 2+ sensitivity in failing hearts Am J Physiol Heart Circ Physiol 281 H637 H646 11454567 1:CAS:528:DC%2BD3MXmtVCls7g%3D
95. N Kobayashi S Horinaka S Mita S Nakano T Honda K Yoshida T Kobayashi H Matsuoka 2002 Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts Cardiovasc Res 55 757 767 12176125 1:CAS:528:DC%2BD38XmtlCqt7g%3D
96. S Demiryurek AF Kara A Celik A Babul M Tarakcioglu AT Demiryurek 2005 Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats Eur J Pharmacol 527 129 140 16307738 (Pubitemid 41745160)
97. S Sanada H Asanuma O Tsukamoto T Minamino K Node S Takashima T Fukushima A Ogai Y Shinozaki M Fujita A Hirata H Okuda H Shimokawa H Tomoike M Hori M Kitakaze 2004 Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C Circulation 110 51 57 15210595 1:CAS:528:DC%2BD2cXlt1Slu7c%3D
98. OC Manintveld PD Verdouw DJ Duncker 2007 The RISK of ROCK Am J Physiol Heart Circ Physiol 292 H2563 H2565 17308009 1:CAS:528:DC%2BD2sXmvF2ltLo%3D
99. N Kobayashi H Takeshima H Fukushima W Koguchi Y Mamada H Hirata Y Machida M Shinoda N Suzuki F Yokotsuka K Tabei H Matsuoka 2009 Cardioprotective effects of pitavastatin on cardiac performance and remodeling in failing rat hearts Am J Hypertension 22 176 182 1:CAS:528:DC%2BD1MXotVKjtQ%3D%3D
100. J Dulak A Jozkowicz 2005 Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy Curr Cancer Drug Targets 5 579 594 16375664 1:CAS:528:DC%2BD2MXhtlegsbfO
101. G Fritz B Kaina 2006 Rho GTPases: promising cellular targets for novel anticancer drugs Curr Cancer Drug Targets 6 1 14 16475973 1:CAS:528: DC%2BD28XhtFCrt7o%3D
102. SA Isezuo 2006 The metabolic syndrome: review of current concepts Niger Postgrad Med J 13 247 255 17278322 1:STN:280:DC%2BD2s%2FnvFejsA%3D%3D
103. EB Okon T Szado I Laher B McManus C van Breemen 2003 Augmented contractile response of vascular smooth muscle in a diabetic mouse model J Vasc Res 40 520 530 14646372
104. JR Sowers MA Lester 1999 Diabetes and cardiovascular disease Diabetes Care 22 Suppl 3 C14 C20 10189558
105. A Goldin JA Beckman AM Schmidt MA Creager 2006 Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 597 605 16894049 1:CAS:528:DC%2BD28Xns1Snu70%3D
106. A Hirose T Tanikawa H Mori Y Okada Y Tanaka 2010 Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway FEBS Lett 584 61 66 19944695 1:CAS:528:DC%2BD1MXhsFGgur7I
107. AR Massey L Miao BN Smith J Liu I Kusaka JH Zhang J Tang 2003 Increased RhoA translocation in renal cortex of diabetic rats Life Sci 72 2943 2952 12706482 1:CAS:528:DC%2BD3sXivFGjtLY%3D
108. F Peng D Wu B Gao AJ Ingram B Zhang K Chorneyko R McKenzie JC Krepinsky 2008 RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease Diabetes 57 1683 1692 18356410 1:CAS:528:DC%2BD1cXnsF2is7s%3D
109. DW Nuno JS Harrod KG Lamping 2009 Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice Am J Physiol Heart Circ Physiol 297 H1469 H1477 19666843 1:CAS:528:DC%2BD1MXhtlent7zE
110. T Kanda S Wakino K Homma K Yoshioka S Tatematsu K Hasegawa I Takamatsu N Sugano K Hayashi T Saruta 2006 Rho-kinase as a molecular target for insulin resistance and hypertension FASEB J 20 169 171 16267124 1:CAS:528: DC%2BD28XjsVWhtA%3D%3D
111. E Hu D Lee 2005 Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges Expert Opin Ther Targets 9 715 736 16083339 1:CAS:528:DC%2BD2MXmvFels74%3D
112. V Kolavennu L Zeng H Peng Y Wang FR Danesh 2008 Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control Diabetes 57 714 723 18083785 1:CAS:528:DC%2BD1cXjt1Chur8%3D
113. N Furukawa P Ongusaha WJ Jahng K Araki CS Choi HJ Kim YH Lee K Kaibuchi BB Kahn H Masuzaki JK Kim SW Lee YB Kim 2005 Role of Rho-kinase in regulation of insulin action and glucose homeostasis Cell Metab 2 119 129 16098829 1:CAS:528:DC%2BD2MXps12ht7g%3D
114. DH Lee J Shi NH Jeoung MS Kim JM Zabolotny SW Lee MF White L Wei YB Kim 2009 Targeted disruption of ROCK1 causes insulin resistance in vivo J Biol Chem 284 11776 11780 19276091 1:CAS:528:DC%2BD1MXltVCmtrk%3D
115. S Chang JA Hypolite A Changolkar AJ Wein S Chacko ME DiSanto 2003 Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta Int J Impot Res 15 53 62 12605241 1:CAS:528:DC%2BD3sXjt1ars7Y%3D
116. TJ Bivalacqua HC Champion MF Usta S Cellek K Chitaley RC Webb RL Lewis TM Mills WJ Hellstrom PJ Kadowitz 2004 RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction Proc Natl Acad Sci USA 101 9121 9126 15184671 1:CAS:528: DC%2BD2cXltlWqtr4%3D
117. E Sahai CJ Marshall 2002 RHO-GTPases and cancer Nat Rev Cancer 2 133 142 12635176
118. PJ Keely 2001 Rho GTPases as early markers for tumour progression Lancet 358 1744 1745 11734226 1:STN:280:DC%2BD3MnoslOlug%3D%3D
119. AB Jaffe A Hall 2002 Rho GTPases in transformation and metastasis Adv Cancer Res 84 57 80 11883532 1:CAS:528:DC%2BD38XlsVWqtr8%3D
120. MT Abraham MA Kuriakose PG Sacks H Yee L Chiriboga EL Bearer MD Delacure 2001 Motility-related proteins as markers for head and neck squamous cell cancer Laryngoscope 111 1285 1289 11568556 1:STN:280:DC%2BD3MrisVCqtw%3D%3D
121. K Itoh K Yoshioka H Akedo M Uehata T Ishizaki S Narumiya 1999 An essential part for Rho-associated kinase in the transcellular invasion of tumor cells Nat Med 5 221 225 9930872 1:CAS:528:DyaK1MXntlOisg%3D%3D
122. S Ogata K Morishige K Sawada K Hashimoto S Mabuchi C Kawase C Ooyagi M Sakata T Kimura 2009 Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells Int J Gynecol Cancer 19 1473 1480 19955921
123. AV Somlyo D Bradshaw S Ramos C Murphy CE Myers AP Somlyo 2000 Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells Biochem Biophys Res Commun 269 652 659 10720471 1:CAS:528: DC%2BD3cXhsleqtbc%3D
124. MT Lin BR Lin CC Chang CY Chu HJ Su ST Chen YM Jeng ML Kuo 2007 IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway Int J Cancer 120 2600 2608 17304514 1:CAS:528: DC%2BD2sXkslGitbk%3D
125. K Yoshioka F Matsumura H Akedo K Itoh 1998 Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells J Biol Chem 273 5146 5154 9478968 1:CAS:528:DyaK1cXhs1Cnt7w%3D
126. L del Peso R Hernandez-Alcoceba N Embade A Carnero P Esteve C Paje JC Lacal 1997 Rho proteins induce metastatic properties in vivo Oncogene 15 3047 3057 9444953 1:CAS:528:DyaK1cXmtFKqsQ%3D%3D
127. HW Sun SL Tong J He Q Wang L Zou SJ Ma HY Tan JF Luo HX Wu 2007 RhoA and RhoC-siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway World J Gastroenterol 13 3517 3522 17659701 1:CAS:528:DC%2BD2sXpt1Gltrg%3D
128. EA Clark TR Golub ES Lander RO Hynes 2000 Genomic analysis of metastasis reveals an essential role for RhoC Nature 406 532 535 10952316 1:CAS:528:DC%2BD3cXmtFensbo%3D
129. ML Coleman MF Olson 2002 Rho GTPase signalling pathways in the morphological changes associated with apoptosis Cell Death Differ 9 493 504 11973608 1:CAS:528:DC%2BD38XktF2qs7Y%3D
130. R Vishnubhotla S Sun J Huq M Bulic A Ramesh G Guzman M Cho SC Glover 2007 ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging Lab Invest 87 1149 1158 17876296 1:CAS:528:DC%2BD2sXhtFOksLjI
131. Z Zhou Y Meng S Asrar Z Todorovski Z Jia 2009 A critical role of Rho-kinase ROCK2 in the regulation of spine and synaptic function Neuropharmacology 56 81 89 18718479 1:CAS:528:DC%2BD1MXhsVGkuw%3D%3D
132. P Sterpetti L Marucci C Candelaresi D Toksoz G Alpini L Ugili GS Baroni G Macarri A Benedetti 2006 Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals Am J Physiol Gastrointest Liver Physiol 290 G624 G632 16322093 1:CAS:528:DC%2BD28Xks1SlsLc%3D
133. Q Lu FM Longo H Zhou SM Massa YH Chen 2009 Signaling through Rho GTPase pathway as viable drug target Curr Med Chem 16 1355 1365 19355891 1:CAS:528:DC%2BD1MXltVeqsbk%3D
134. Y Fukumoto T Matoba A Ito H Tanaka T Kishi S Hayashidani K Abe A Takeshita H Shimokawa 2005 Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension Heart 91 391 392 15710736 1:STN:280:DC%2BD2M%2FotFOhtw%3D%3D
135. F Li W Xia A Li C Zhao R Sun 2007 Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats Pharmacol Res 55 64 71 17127075 1:CAS:528:DC%2BD2sXntlCjtA%3D%3D (Pubitemid 46108589)
136. RJ Barst M McGoon A Torbicki O Sitbon MJ Krowka H Olschewski S Gaine 2004 Diagnosis and differential assessment of pulmonary arterial hypertension J Am Coll Cardiol 43 40S 47S 15194177 (Pubitemid 38759716)
137. M Oka N Homma L Taraseviciene-Stewart KG Morris D Kraskauskas N Burns NF Voelkel IF McMurtry 2007 Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats Circ Res 100 923 929 17332430 1:CAS:528:DC%2BD2sXjtlWmsLg%3D
138. Z Do e Y Fukumoto A Takaki S Tawara J Ohashi M Nakano T Tada K Saji K Sugimura H Fujita Y Hoshikawa J Nawata T Kondo H Shimokawa 2009 Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension Circ J 73 1731 1739 19590140
139. F Li W Xia S Yuan R Sun 2009 Acute inhibition of Rho-kinase attenuates pulmonary hypertension in patients with congenital heart disease Pediatr Cardiol 30 363 366 18953591
140. H Fujita Y Fukumoto K Saji K Sugimura J Demachi J Nawata H Shimokawa 2010 Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension Heart Vessel 25 144 149
141. C Guilluy V Sauzeau M Rolli-Derkinderen P Guerin C Sagan P Pacaud G Loirand 2005 Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension Br J Pharmacol 146 1010 1018 16205723 1:CAS:528:DC%2BD2MXht1Ghu7vP
142. JM Hyvelin K Howell A Nichol CM Costello RJ Preston P McLoughlin 2005 Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation Circ Res 97 185 191 15961717 1:CAS:528: DC%2BD2MXmtFSlt7g%3D
143. T Nagaoka KA Fagan SA Gebb KG Morris T Suzuki H Shimokawa IF McMurtry M Oka 2005 Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension Am J Respir Crit Care Med 171 494 499 15563635
144. N Homma T Nagaoka V Karoor M Imamura L Taraseviciene-Stewart LA Walker KA Fagan IF McMurtry M Oka 2008 Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone Am J Physiol Lung Cell Mol Physiol 295 L71 L78 18469113 1:CAS:528:DC%2BD1cXoslygsb0%3D
145. T Nagaoka SA Gebb V Karoor N Homma KG Morris IF McMurtry M Oka 2006 Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat J Appl Physiol 100 996 1002 16322374 1:CAS:528: DC%2BD28Xis1Sns74%3D
146. BR Broughton BR Walker TC Resta 2008 Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries Am J Physiol Lung Cell Mol Physiol 294 L797 L806 18263668 1:CAS:528:DC%2BD1cXkslOqsbk%3D
147. KA Fagan M Oka NR Bauer SA Gebb DD Ivy KG Morris IF McMurtry 2004 Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase Am J Physiol Lung Cell Mol Physiol 287 L656 L664 14977625 1:CAS:528:DC%2BD2cXptVyhs7k%3D
148. C Guilluy M Rolli-Derkinderen PL Tharaux G Melino P Pacaud G Loirand 2007 Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells J Biol Chem 282 2918 2928 17142836 1:CAS:528:DC%2BD2sXptFCmtw%3D%3D
149. C Guilluy S Eddahibi C Agard C Guignabert M Izikki L Tu L Savale M Humbert E Fadel S Adnot G Loirand P Pacaud 2009 RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling Am J Respir Crit Care Med 179 1151 1158 19299501 1:CAS:528:DC%2BD1MXotV2ht7g%3D
150. L Taraseviciene-Stewart R Scerbavicius KH Choe C Cool K Wood RM Tuder N Burns M Kasper NF Voelkel 2006 Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension Am J Physiol Lung Cell Mol Physiol 291 L668 L676 16698853 1:CAS:528:DC%2BD28XhtFarsLnN
151. N Toda K Ayajiki T Okamura 2005 Nitric oxide and penile erectile function Pharmacol Ther 106 233 266 15866322 1:CAS:528:DC%2BD2MXjs1Cmtbg%3D
152. TJ Bivalacqua T Liu B Musicki HC Champion AL Burnett 2007 Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis Eur Urol 51 1732 1740 17113219 1:CAS:528:DC%2BD2sXntFOmtbw%3D
153. Dean RC, Lue TF (2005) Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am 32:379-395
154. S Puetz LT Lubomirov G Pfitzer 2009 Regulation of smooth muscle contraction by small GTPases Physiology (Bethesda) 24 342 356 1:CAS:528:DC%2BC3cXht1ais78%3D
155. TM Mills RW Lewis CJ Wingard AE Linder L Jin RC Webb 2003 Vasoconstriction, RhoA/Rho-kinase and the erectile response Int J Impot Res 15 Suppl 5 S20 S24 14551573 1:CAS:528:DC%2BD3sXovFWitL0%3D
156. L Jin AL Burnett 2006 RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights Clin Sci (Lond) 110 153 165 1:CAS:528:DC%2BD28XmtlOrtg%3D%3D
157. K Chitaley CJ Wingard R Clinton Webb H Branam VS Stopper RW Lewis TM Mills 2001 Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway Nat Med 7 119 122 11135626 1:CAS:528: DC%2BD3MXmvFWrsw%3D%3D
158. K Chitaley RC Webb AM Dorrance TM Mills 2001 Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats Int J Impot Res 13 Suppl 5 S16 S20 11781742
159. M Burchardt T Burchardt L Baer AJ Kiss RV Pawar A Shabsigh A de la Taille OR Hayek R Shabsigh 2000 Hypertension is associated with severe erectile dysfunction J Urol 164 1188 1191 10992363 1:STN:280:DC%2BD3cvksV2gsg%3D%3D
160. R Shabsigh 2004 Testosterone therapy in erectile dysfunction Aging Male 7 312 318 15799127 1:CAS:528:DC%2BD2MXht1KisLk%3D
161. HA Feldman CB Johannes CA Derby KP Kleinman BA Mohr AB Araujo JB McKinlay 2000 Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study Prev Med 30 328 338 10731462 1:STN:280:DC%2BD3c7pvVCqsg%3D%3D
162. RA Kloner 2008 Erectile dysfunction: the new harbinger for major adverse cardiac events in the diabetic patient J Am Coll Cardiol 51 2051 2052 18498960
163. K Buyukafsar I Un 2003 Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice Eur J Pharmacol 472 235 238 12871759 1:CAS:528:DC%2BD3sXlsVamt7w%3D
164. CJ Wingard JA Johnson A Holmes A Prikosh 2003 Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction Am J Physiol Regul Integr Comp Physiol 284 R1572 R1579 12573976 1:CAS:528: DC%2BD3sXltVehtbg%3D
165. L Vignozzi A Morelli S Filippi S Ambrosini R Mancina M Luconi S Mungai GB Vannelli XH Zhang G Forti M Maggi 2007 Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes J Sex Med 4 620 630 17498101 1:CAS:528:DC%2BD2sXmsFOhurY%3D (discussion 631-632)
166. M Rajasekaran S White A Baquir N Wilkes 2005 Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats J Androl 26 182 188 15713824 1:CAS:528:DC%2BD2MXis1Slurg%3D
167. L Jin T Liu GA Lagoda HC Champion TJ Bivalacqua AL Burnett 2006 Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction FASEB J 20 536 538 16396994 1:CAS:528:DC%2BD28Xis1yqurk%3D
168. TM Seasholtz J Wessel F Rao BK Rana S Khandrika BP Kennedy EO Lillie MG Ziegler DW Smith NJ Schork JH Brown DT O'Connor 2006 Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity Hypertension 47 937 947 16585408 1:CAS:528:DC%2BD28XjsVeksL4%3D